# Atorvastatin in Active Vitiligo

> **NCT02432534** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 28 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Atorvastatin
- **OTHER:** UVB

## Key facts

- **NCT ID:** NCT02432534
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-02
- **Final completion:** 2017-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432534, "Atorvastatin in Active Vitiligo". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02432534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*